Novo Nordisk’s recent introduction of a direct-to-patient delivery model for its weight-loss drug Wegovy in the United States ...
Wegovy (semaglutide) and Mounjaro (tirzepatide) are brand-name injections. Wegovy is prescribed for weight loss and to lower cardiovascular risks. Mounjaro is approved for type 2 diabetes, and ...
Novo Nordisk’s recent introduction of a direct-to-patient delivery model for its weight-loss drug Wegovy in the United States could potentially delay its availability in India, industry analysts ...